Skip to content

Clinical trials

Phase 3 Melanoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 3 Country / region: Germany Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20042
20051
20063
20072
20082
20092
20103
20112
20125
20136
20141
20152
20163
20174
20183
20192
20202
20213
20224
20236
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Active, not recruiting13
Terminated12
Unknown status8
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb14
Hoffmann-La Roche5
European Organisation for Research and Treatment of Cancer - EORTC4
Merck Sharp & Dohme LLC4
Novartis Pharmaceuticals4
GlaxoSmithKline3
Pfizer3
Amgen2
CancerVax Corporation2
Celgene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma68
Neoplasm Metastasis11
Skin Neoplasms11
Neoplasms6
Brain Neoplasms2
Skin Diseases2
Nevus, Blue1
Recurrence1
Uveal Melanoma1

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.